A recent study using postmortem brain samples exhibited reduced Keap1 and Nrf2 expression levels in the parietal cortex of depressed patients (Zhang et al., 2018), suggesting that decreased Keap1-Nrf2 signaling plays a role in depression. Here, KEAP1 is linked to depressive symptom measurement.